Your search for dabigatran returned 116 results

Your search for dabigatran returned 116 results

Sort Results:

Relevant Recent
Drug Monograph

PRADAXA

Dabigatran etexilate mesylate 75mg, 110mg, 150mg; caps.
Drugs in the Pipeline

Dabigatran Comparable to Warfarin in DVT/PE Trial

Boehringer Ingelheim announced results from the RE-COVER II study evaluating dabigatran compared to warfarin in patients diagnosed with acute deep vein thrombosis (DVT) and/or pulmonary embolism (PE).
News

Factors Associated with Greater Dabigatran Adherence

Appropriate patient selection and pharmacist-led monitoring were linked to greater adherence to dabigatran among patients with atrial fibrillation at Veterans Health Administration sites, according to a recent study published in JAMA.
American College of Cardiology 2011

Dabigatran Etexilate vs. Warfarin in Different Types of Atrial Fibrillation

A subgroup analysis from the RE-LY trial has demonstrated that in patients with atrial fibrillation (AF), twice-daily dabigatran etexilate has better efficacy and lower rates of major bleeding when compared with warfarin, as reported at ACC.11, the American College of Cardiology's 60th Annual Scientific Session.